154 related articles for article (PubMed ID: 10474613)
1. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
Sullivan LG
Med J Aust; 1999 Aug; 171(3):165-6. PubMed ID: 10474613
[No Abstract] [Full Text] [Related]
2. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
Crofts N; Aitken CK; Kaldor JM
Med J Aust; 1999 Mar; 170(5):220-1. PubMed ID: 10092920
[No Abstract] [Full Text] [Related]
3. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
Copeman M
Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
[No Abstract] [Full Text] [Related]
4. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
[TBL] [Abstract][Full Text] [Related]
5. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users.
Kretzschmar M; Wiessing L
AIDS; 2008 Aug; 22(13):1527-37. PubMed ID: 18670211
[TBL] [Abstract][Full Text] [Related]
6. Once more unto the breach: controlling hepatitis C in injecting drug users.
Wodak A; Crofts N
Addiction; 1996 Feb; 91(2):181-4. PubMed ID: 8835275
[No Abstract] [Full Text] [Related]
7. Syringe exchanges: a public health response to problem drug use.
Cox GM; Lawless MC; Cassin SP; Geoghegan TW
Ir Med J; 2000; 93(5):143-6. PubMed ID: 11072923
[TBL] [Abstract][Full Text] [Related]
8. Managing HIV. Part 8: Controlling an epidemic. 8.5 HIV prevention in the community: injecting drug users.
Wodak A; Dolan K
Med J Aust; 1996 Sep; 165(5):266-7. PubMed ID: 8816685
[TBL] [Abstract][Full Text] [Related]
9. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
10. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
Law MG; Batey RG
Med J Aust; 2003 Mar; 178(5):197-8. PubMed ID: 12603178
[No Abstract] [Full Text] [Related]
11. Preventing transmission of hepatitis C.
MacDonald M; Wodak A
Aust Fam Physician; 2003 Oct; 32(10):799-803. PubMed ID: 14596074
[No Abstract] [Full Text] [Related]
12. The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia.
Day C; Degenhardt L; Gilmour S; Hall W
BMC Public Health; 2005 Aug; 5():84. PubMed ID: 16102177
[TBL] [Abstract][Full Text] [Related]
13. Needle exchange: why don't the feds get the point?
Beaubien G
Posit Aware; 1997; 8(2):36-40. PubMed ID: 11364456
[TBL] [Abstract][Full Text] [Related]
14. Thinking ethically about needle and syringe programs.
Kleinig J
Subst Use Misuse; 2006; 41(6-7):815-25. PubMed ID: 16809168
[TBL] [Abstract][Full Text] [Related]
15. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
16. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
17. Strategies to improve access to sterile syringes for injection drug users.
Rich JD; Wolf FA; Macalino G
AIDS Read; 2002 Dec; 12(12):527-35. PubMed ID: 12518719
[TBL] [Abstract][Full Text] [Related]
18. Preventing the transmission of bloodborne pathogens in health care and public service settings.
Can Commun Dis Rep; 1997 May; 23 Suppl 3():i-vii, 1-43, i-vii, 1-52. PubMed ID: 11195251
[No Abstract] [Full Text] [Related]
19. Modelling the hepatitis C virus epidemic in Australia.
Razali K; Thein HH; Bell J; Cooper-Stanbury M; Dolan K; Dore G; George J; Kaldor J; Karvelas M; Li J; Maher L; McGregor S; Hellard M; Poeder F; Quaine J; Stewart K; Tyrrell H; Weltman M; Westcott O; Wodak A; Law M
Drug Alcohol Depend; 2007 Dec; 91(2-3):228-35. PubMed ID: 17669601
[TBL] [Abstract][Full Text] [Related]
20. Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey.
Day CA; Topp L; Iversen J; Maher L;
Drug Alcohol Rev; 2008 Sep; 27(5):559-61. PubMed ID: 18608447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
